Creatinine Assay Kits Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Creatinine Assay Kits Market is Segmented by Type (Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits, and ELISA Test Kits), Type of Sample (Blood/Serum, Urine, and Other Samples), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Creatinine Assay Kits Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Creatinine Assay Kits Market Size

Creatinine Assay Kits Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Creatinine Assay Kits Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Creatinine Assay Kits Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Creatinine Assay Kits Market Analysis

The Creatinine Assay Kits Market is expected to register a CAGR of 5.3% during the forecast period.

  • There was a significant COVID-19 impact observed on the market studied. This was majorly attributed to the occurrence of kidney diseases among the individuals who suffered from COVID-19. The patients who survived COVID-19 exhibited an increased risk of acute kidney injury (AKI), estimated glomerular filtration rate (eGFR) declined, end-stage kidney disease (ESKD), and significant adverse kidney events (MAKE). The risks (and burdens) of kidney outcomes increased according to the severity of the acute infection. Thus, due to the high incidence rate of COVID-19, the burden of kidney diseases increased worldwide, which propelled the demand for creatinine assay kits to detect and diagnose kidney diseases and boosted the growth of the market studied. However, the market studied is currently performing at a pre-pandemic pace as COVID-19 illness and its associated impact have declined.
  • The increasing incidence of renal and other chronic disorders, technological advancements in biomedical research about kidney disorders, and increasing research and development initiatives are the key driving factors in the creatinine assay kits market. Creatinine assay kits measure creatinine levels in serum/plasma, urine, and other biological samples. Creatinine assay is used to analyze the protein metabolism in the body, and the creatinine levels can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and deflect in the blood test if the kidney is not in good condition. The creatinine test is performed by using a specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes, and cancers. 
  • According to the International Society of Nephrology 2021 data, yearly, approximately 13.3 million cases of acute kidney injury (AKI) globally are exceptionally high in emerging countries, where annual incidence is estimated to be 11.3 million. Hence, with the increasing burden of kidney diseases, there is a growing demand for creatinine assay kits for diagnosis purposes, fueling the market growth worldwide.
  • Furthermore, as per Globocan, the burden of cancer is expected to reach 605,726 cases by 2040. The high burden of kidney cancer boosted the early detection of kidney diseases, thereby driving the renal biomarkers market. According to the research study published in April 2021, titled, Global epidemiology of end-stage kidney disease (ESKD) and disparities in kidney replacement therapy, end-stage kidney disease (ESKD) was a rapidly increasing global health and healthcare burden, and the average number of new ESKD diagnoses worldwide was 144 individuals per million general population. Thus, the demand for renal biomarkers for detecting and diagnosing ESKD is expected to increase, likely to boost the growth in the market studied.
  • However, identifying novel renal biomarkers and the limited usage of creatinine assay kits in in-vitro diagnostic devices hinder the global market growth.

Creatinine Assay Kits Industry Overview

The creatinine assay kits market is highly fragmented and competitive and consists of several major players. In terms of market share, the majority of the players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation, Cell Biolabs Inc., Genway Biotech, Randox Laboratories Ltd, ACON Laboratories, Nova Biomedical, and Sysmex India Pvt. Ltd.

Creatinine Assay Kits Market Leaders

  1. Abbott Laboratories

  2. Thermo Fisher Scientific

  3. Merck KGaA

  4. Quidel Corporation

  5. Cell Biolabs, Inc

  6. *Disclaimer: Major Players sorted in no particular order
Creatinine Assay Kits Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Creatinine Assay Kits Market News

  • July 2022: Creative Enzymes, one of the leading diagnostic enzyme production companies, launched new enzymes for the production of creatinine assay kits.
  • June 2022: Nova Biomedical launched the CE-marked Nova Max Pro creatinine/eGFR meter system in the European market. Nova Max Pro was designed to improve kidney care through kidney function screening and early detection of kidney disease in point-of-care settings outside the hospital.

Creatinine Assay Kits Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Renal and Other Chronic Disorders Impacting Renal Function
    • 4.2.2 Technological Advancements in Biomedical Research Pertaining to Kidney Disorders
    • 4.2.3 Increasing Research and Development Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Identification of Novel Renal Dysfunction Biomarkers
    • 4.3.2 Limited Usage of Creatinine Assay Kits in Invitro Diagnostic Device (IVD)
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size - in USD million)

  • 5.1 By Type
    • 5.1.1 Jaffe's Kinetic Test kits
    • 5.1.2 Creatinine-PAP Test kits
    • 5.1.3 ELISA Test kits
  • 5.2 By Type of Sample
    • 5.2.1 Blood/Serum
    • 5.2.2 Urine
    • 5.2.3 Other Samples
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Quidel Corporation
    • 6.1.5 Cell Biolabs, Inc
    • 6.1.6 Genway Biotech (Aviva Systems Biology LLC)
    • 6.1.7 Randox Laboratories Ltd
    • 6.1.8 ACON Laboratories
    • 6.1.9 Nova Biomedical
    • 6.1.10 Sysmex Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Creatinine Assay Kits Industry Segmentation

As per the scope of this report, creatinine assay kits are used to measure creatinine levels in serum/plasma, urine, and other biological samples. The creatinine assay kits market is segmented by type (Jaffe's kinetic test kits, creatinine-PAP test kits, and ELISA test kits), type of sample (blood/serum, urine, and other samples), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type Jaffe's Kinetic Test kits
Creatinine-PAP Test kits
ELISA Test kits
By Type of Sample Blood/Serum
Urine
Other Samples
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Creatinine Assay Kits Market Research FAQs

What is the current Creatinine Assay Kits Market size?

The Creatinine Assay Kits Market is projected to register a CAGR of 5.3% during the forecast period (2025-2030)

Who are the key players in Creatinine Assay Kits Market?

Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation and Cell Biolabs, Inc are the major companies operating in the Creatinine Assay Kits Market.

Which is the fastest growing region in Creatinine Assay Kits Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Creatinine Assay Kits Market?

In 2025, the North America accounts for the largest market share in Creatinine Assay Kits Market.

What years does this Creatinine Assay Kits Market cover?

The report covers the Creatinine Assay Kits Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Creatinine Assay Kits Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Creatinine Assay Kits Industry Report

Statistics for the 2025 Creatinine Assay Kits market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Creatinine Assay Kits analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.